Squamous Cell Carcinoma in the Lower Third of the Esophagus: A Case Report
Main Article Content
Abstract
Esophageal squamous cell carcinoma usually predominates in the flat cells of the upper two thirds of the esophagus and is rare in the distal third due to histologic characteristics. Smoking and alcoholism are the most important associated risk factors and the predominant symptom is dysphagia. Surgery is the treatment of choice in localized disease; in advanced stages chemotherapy is used for palliative purposes. We present the clinical case of a 77-year-old man with a history of significant positive alcoholism and smoking and systemic arterial hypertension. He presented 2 months of evolution with progressive dysphagia, from liquids to solids, anorexia and hematemesis. Endoscopy reports linear erosions in the gastroesophageal junction with a stenosing, infiltrative and partially ulcerated tumor. Computed axial tomography with evidence of hepatic nodules compatible with distant activity. He was referred to general surgery for gastrostomy for enteral tube feeding and to medical oncology for treatment with chemotherapy with palliative intent.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Arnold, M., Soerjomataram, I., Ferlay, J., & Forman, D. (2015). Global incidence of oesophageal cancer by histological subtype in 2012. Gut, 64(3), 381-387.https://doi.org/10.1136/gutjnl-2014-308124)
II. Brenes TZSA. Bibliographic Review of Esophageal Cancer. Medical Journal of Costa Rica and Central America LX-X 2012:539-44.
III. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med [Internet]. 2003;349(23):2241–52. Available at: http://dx.doi.org/10.1056/NEJMra035010
IV. Villalobos Pérez JJ, Bourlon MT, Loaeza Del Castillo A, Torres Villalobos G. A 35-year report of the study of group on gastrointestinal cancer in Mexico City: variations in frequency of different digestive tract neoplasms among different socioeconomic statuses. Gac Med Mex 150(1):49-57. Available at:
https://pubmed.ncbi.nlm.nih.gov/24481431/
V. Uhlenhopp, D. J., Then, E. O., Sunkara, T., & Gaduputi, V. (2020). Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clinical Journal of Gastroenterology, 13(6), 1010-1021. https://doi.org/10.1007/s12328-020-01237-x.
VI. Napier, K. J., Scheerer, M., & Misra, S. (2014). Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World Journal of Gastrointestinal Oncology, 6(5), 112-120.
https://doi.org/10.4251/wjgo.v6.i5.112.
VII. (Hermida Pérez JA, Bermejo Hernández A, Sobenes Gutierrez RJ, Arroyo Díaz R. Esophageal squamous cell carcinoma, stenosing, stage IV, in a 41-year-old woman. Description of a clinical case. Semergen 2012;38:44-8).
VIII. Encinas de la Iglesia J, Corral de la Calle MA, Fernández Pérez GC, Ruano Pérez R, Álvarez Delgado A. Esophageal cancer: anatomical peculiarities, staging and imaging techniques. Radiology 58(5):352-65. Available at: https://www.elsevier.es/es-revista-radiologia-119-articulo-cancer-esofago-particularidades-anatomicas-estadificacion-S0033833816300741
IX. Escrig Sos J, Gómez Quiles L, Maiocchi K. The 8.a edition of the AJCC-TNM classification: new contributions to the staging of esophagogastric junction cancer. Cir Esp (Engl Ed) 97(8):432-7. Available at: https://www.elsevier.es/es-revista-cirugia-espanola-36-pdf-S0009739X1930096X
X. Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg 2017 6(2):119-30. Available at: http://dx.doi.org/10.21037/acs.2017.03.14